December 4, 2022

Updated COVID-19 boosters for 5- to 11-year-olds will be authorized in the coming weeks, a Food and Drug Administration official said this week. According to ABC News,

– Advertisement –

New boosters developed by BioNTech BNTX,
/pfizer pfe,
and modern mRNA,
Protect against the original strain of the virus as well as the new BA.4 and BA.5 subvariants, which currently account for about 85% of all cases worldwide.

– Advertisement –

“I believe we are only a few weeks away,” Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, told an event Tuesday.

The shots are expected to be rolled out to different age groups as seen earlier. They will likely be available first to children ages 5 to 11 and then to younger children.

– Advertisement –

That said, the uptake of the COVID-19 vaccine for children has been low. Only about 9.3 million children under the age of 12 are fully vaccinated. There are about 43 million children in the US who are 10 years of age or younger.

Other COVID-19 news to know:

See also  5 reasons why now is the time to retire overseas